UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)

The lancet oncology, 2010-03, Vol.11 (3), p.266-274

2010

Volltextzugriff (PDF)

Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study

Clinical cancer research, 2008-02, Vol.14 (4), p.1096-1104

2008

Volltextzugriff (PDF)

Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial

Journal of clinical oncology, 2008-11, Vol.26 (31), p.5027-5035

2008

Volltextzugriff (PDF)

In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer

Breast cancer research and treatment, 2012-04, Vol.132 (2), p.463-470

2012

Volltextzugriff (PDF)

CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer

Clinical and translational radiation oncology, 2020-11, Vol.25, p.61-66

2020

Volltextzugriff (PDF)

Xeloda® in Adjuvant Colon Cancer Therapy (X-ACT) Trial: Overview of Efficacy, Safety, and Cost-Effectiveness

Clinical colorectal cancer, 2006-11, Vol.6 (4), p.278-287

Twelves, Chris J.

2006

Volltextzugriff (PDF)

Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients

Cancer immunology research, 2022-06, Vol.10 (6), p.745-756

2022

Volltextzugriff (PDF)

Defining the optimal schedule of drug administration: art or science?

Journal of clinical oncology, 2008-04, Vol.26 (11), p.1781-1782

Twelves, Chris J

2008

Volltextzugriff (PDF)

Sunbed use in children aged 11-17 in England: face to face quota sampling surveys in the National Prevalence Study and Six Cities Study

BMJ, 2010-03, Vol.340 (mar18 2), p.c877-c877

2010

Volltextzugriff (PDF)

Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study

Clinical colorectal cancer, 2005-07, Vol.5 (2), p.101

2005

Volltextzugriff (PDF)

Capecitabine in colorectal cancer

Therapy, 2009-03, Vol.6 (2), p.239-248

2009

Volltextzugriff (PDF)

Quality of Life in Women with Advanced Breast Cancer Treated with Docetaxel

Clinical breast cancer, 2004-08, Vol.5 (3), p.216-222

2004

Volltextzugriff (PDF)

Abstract 5507: The development and evaluation of a model for assessing convective fluid flow through multicell layers in vitro

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.5507-5507

2010

Volltextzugriff (PDF)

Capecitabine/Oxaliplatin, a Safe and Active First-Line Regimen for Older Patients Metastatic Colorectal Cancer: Post Hoc Analysis of a Large Phase II Study

Clinical colorectal cancer, 2005-07, Vol.5 (2), p.101-107

2005

Volltextzugriff (PDF)

DNA: still a target worth aiming at? A review of new DNA-interactive agents

American journal of pharmacogenomics, 2001, Vol.1 (1), p.67-81

2001

Volltextzugriff (PDF)

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

The New England journal of medicine, 2005-06, Vol.352 (26), p.2696-2704

2005

Volltextzugriff (PDF)

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

The lancet oncology, 2014-12, Vol.15 (13), p.1481-1492

2014

Volltextzugriff (PDF)

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials

European journal of cancer (1990), 2012-05, Vol.48 (8), p.1176-1184

2012

Volltextzugriff (PDF)

Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study

Journal of clinical oncology, 2001-11, Vol.19 (21), p.4097-4106

2001

Volltextzugriff (PDF)

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer

JNCI : Journal of the National Cancer Institute, 2014-12, Vol.106 (12), p.1

2014

Volltextzugriff (PDF)

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial

The lancet oncology, 2020-03, Vol.21 (3), p.345-357

2020

Volltextzugriff (PDF)

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

The New England journal of medicine, 2017-07, Vol.377 (2), p.122-131

2017

Volltextzugriff (PDF)

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

The Lancet infectious diseases, 2022-08, Vol.22 (8), p.1131-1141

2022

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(69)
Oncology
(57)
Humans
(56)
Female
(43)
Middle Aged
(36)
Adult
(29)
Aged
(28)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Male
(25)
Tumors
(25)
Chemotherapy
(23)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Capecitabine
(18)
Breast Neoplasms - Drug Therapy
(16)
Deoxycytidine - Analogs & Derivatives
(16)
Fluorouracil - Analogs & Derivatives
(16)
Pharmacology. Drug Treatments
(15)
Breast Cancer
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)

Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study

Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial

In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer

CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer

Xeloda® in Adjuvant Colon Cancer Therapy (X-ACT) Trial: Overview of Efficacy, Safety, and Cost-Effectiveness

Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients

Defining the optimal schedule of drug administration: art or science?

Sunbed use in children aged 11-17 in England: face to face quota sampling surveys in the National Prevalence Study and Six Cities Study

Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study

Capecitabine in colorectal cancer

Quality of Life in Women with Advanced Breast Cancer Treated with Docetaxel

Abstract 5507: The development and evaluation of a model for assessing convective fluid flow through multicell layers in vitro

Capecitabine/Oxaliplatin, a Safe and Active First-Line Regimen for Older Patients Metastatic Colorectal Cancer: Post Hoc Analysis of a Large Phase II Study

DNA: still a target worth aiming at? A review of new DNA-interactive agents

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: A pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials

Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Suchergebnisse filtern